//FDA notes shortages of 2 drugs after they were touted by President Trump

FDA notes shortages of 2 drugs after they were touted by President Trump

The FDA says it has shortages of two drugs that have gained a lot of attention in recent weeks. Hydroxychloroquine is a drug you’ve probably heard a lot about lately. President Donald Trump mentioned it as a possible treatment for COVID-19, even though doctors say there’s no evidence it works on coronavirus patients. Now the Food and Drug Administration says there’s a shortage of that drug and chloroquine.It posted that information on its drug shortages webpage. The FDA says there’s a significant surge in demand, making it difficult for people who need the medication to get it. The drugs are used to treat malaria, lupus and rheumatoid arthritis.Manufacturers are now ramping up production.The federal agency is announcing this shortage just a couple of days after giving the green light to hospitals across the country to use the drug on coronavirus patients who are seriously ill, saying it’s worth the risk to try it — despite the lack of clinical trials.

The FDA says it has shortages of two drugs that have gained a lot of attention in recent weeks.

Hydroxychloroquine is a drug you’ve probably heard a lot about lately. President Donald Trump mentioned it as a possible treatment for COVID-19, even though doctors say there’s no evidence it works on coronavirus patients.

Advertisement

Now the Food and Drug Administration says there’s a shortage of that drug and chloroquine.

It posted that information on its drug shortages webpage. The FDA says there’s a significant surge in demand, making it difficult for people who need the medication to get it.

The drugs are used to treat malaria, lupus and rheumatoid arthritis.

Manufacturers are now ramping up production.

The federal agency is announcing this shortage just a couple of days after giving the green light to hospitals across the country to use the drug on coronavirus patients who are seriously ill, saying it’s worth the risk to try it — despite the lack of clinical trials.